  Background and Purpose: Biopsy is the main determinants of glioma clinical
management, but require invasive sampling that fail to detect relevant features
because of tumor heterogeneity. The purpose of this study was to evaluate the
accuracy of a voxel-wise, multiparametric MRI radiomic method to predict
features and develop a minimally invasive method to objectively assess
neoplasms.
  Methods: Multiparametric MRI were registered to T1-weighted gadolinium
contrast-enhanced data using a 12 degree-of-freedom affine model. The
retrospectively collected MRI data included T1-weighted, T1-weighted gadolinium
contrast-enhanced, T2-weighted, fluid attenuated inversion recovery, and
multi-b-value diffusion-weighted acquired at 1.5T or 3.0T. Clinical experts
provided voxel-wise annotations for five disease states on a subset of patients
to establish a training feature vector of 611,930 observations. Then, a
k-nearest-neighbor (k-NN) classifier was trained using a 25% hold-out design.
The trained k-NN model was applied to 13,018,171 observations from seventeen
histologically confirmed glioma patients. Linear regression tested overall
survival (OS) relationship to predicted disease compositions (PDC) and
diagnostic age (alpha = 0.05). Canonical discriminant analysis tested if PDC
and diagnostic age could differentiate clinical, genetic, and microscopic
factors (alpha = 0.05).
  Results: The model predicted voxel annotation class with a Dice similarity
coefficient of 94.34% +/- 2.98. Linear combinations of PDCs and diagnostic age
predicted OS (p = 0.008), grade (p = 0.014), and endothelia proliferation (p =
0.003); but fell short predicting gene mutations for TP53BP1 and IDH1.
  Conclusions: This voxel-wise, multi-parametric MRI radiomic strategy holds
potential as a non-invasive decision-making aid for clinicians managing
patients with glioma.
